https://pharminent.com/novartis-acquires-uk-adc-specialist-myricx-bio-for-up-to-1-5-billion/ 2026-07-06T18:02:55Z Pharminent en Novartis Acquires UK ADC Specialist Myricx Bio for Up to $1.5 Billion 2026-07-06T18:02:51Z Blog https://pharminent.com/strategic-news-watch/strategic-news-watch-july-6-2026/ 2026-07-06T15:44:57Z Pharminent en Strategic News Watch • July 6, 2026 2026-07-06T15:44:55Z Blog https://pharminent.com/novartis-to-acquire-myricx-bio-in-up-to-1-5bn-deal/ 2026-07-06T17:37:08Z Pharminent en Novartis to acquire Myricx Bio in up to $1.5bn deal 2026-07-06T10:49:45Z Blog https://pharminent.com/uk-pharma-industry-pilot-rapid-access-routes-for-medicines/ 2026-07-06T17:36:04Z Pharminent en UK, pharma industry pilot rapid access routes for medicines 2026-07-05T18:49:53Z Blog https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-july-3-2026/ 2026-07-04T14:44:42Z Pharminent en GLP-1 Competitive Market Digest • Weekly • July 3, 2026 2026-07-04T14:44:40Z Blog